Activities per year
Activities
- 14 results
Search results
-
Pharmacology of electrophilic NRF2 activators
Dinkova-Kostova, A. (Speaker)
8 Feb 2024Activity: Talk or presentation types › Invited talk
-
Electrophiles and KEAP1-NRF2 protein-protein interaction inhibitors for prevention and treatment of chronic disease
Dinkova-Kostova, A. (Speaker)
5 Jun 2024Activity: Talk or presentation types › Invited talk
-
Nrf2 activation by electrophilic metabolites
Dinkova-Kostova, A. (Speaker)
18 Apr 2024Activity: Talk or presentation types › Invited talk
-
Nrf2 depletion leads to mitolysosome accumulation
Dinkova-Kostova, A. (Speaker)
4 Nov 2023Activity: Talk or presentation types › Invited talk
-
The utility of the cellular thermal shift assay for monitoring target engagement by Keap1-Nrf2 protein-protein interaction inhibitors
Dinkova-Kostova, A. (Speaker)
12 Oct 2023Activity: Talk or presentation types › Invited talk
-
Nrf2 depletion in the context of Keap1 loss-of-function leads to mitolysosome accumulation
Dinkova-Kostova, A. (Speaker)
31 Oct 2023Activity: Talk or presentation types › Invited talk
-
Nrf2 depletion leads to impaired mitochondrial respiration and mitolysosome accumulation
Dinkova-Kostova, A. (Speaker)
19 Apr 2023Activity: Talk or presentation types › Invited talk
-
The anti-inflammatory activity of transcription factor Nrf2
Dinkova-Kostova, A. (Speaker)
10 Jan 2022Activity: Talk or presentation types › Invited talk
-
The role of Nrf2 for mitochondrial adaptation in inflammatory macrophages
Dinkova-Kostova, A. (Speaker)
24 Aug 2022Activity: Talk or presentation types › Invited talk
-
Targeting KEAP1 with electrophiles and KEAP1-NRF2 protein-protein interaction inhibitors for disease prevention and treatment
Dinkova-Kostova, A. (Speaker)
21 Mar 2022Activity: Talk or presentation types › Invited talk
-
Nrf2 – Keap1 System
Dinkova-Kostova, A. (Speaker)
21 Sept 2022Activity: Talk or presentation types › Invited talk
-
Keap1/Nrf2 as a druggable target
Dinkova-Kostova, A. (Speaker)
15 Oct 2022Activity: Talk or presentation types › Invited talk
-
Keap1/Nrf2 as a druggable target
Dinkova-Kostova, A. (Speaker)
2021Activity: Talk or presentation types › Invited talk
-
Breaking the vicious cycle of oxidative stress – inflammation – cell death by reversible cysteine modifications of Keap1
Dinkova-Kostova, A. (Speaker)
2021Activity: Talk or presentation types › Invited talk